FDA Inspection 1067755 — Exela Pharma Sciences LLC

Exela Pharma Sciences LLC — FEI 3008563008

The FDA completed an inspection of Exela Pharma Sciences LLC on September 11, 2018 in Lenoir, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 11, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Lenoir, NC (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)